The searchable archive below contains a list of Knight ADRC Tuesday Seminar presenters, the date of their presentation, institutional affiliation, and the title of their talk. The archive starts in 2000 with listings displayed in reverse chronological order (most recent first). Note that prior to 2020, some events may be missing or inaccurate due to last minute changes/cancellations.
Total Entries: 1317
| Date | Presenter | Affiliation | Title |
|---|---|---|---|
| August 3, 2021 | Eric McDade, DO | WashU Medicine | A trial of gantenerumab or solanezumab indominantly inherited Alzheimer’s disease- The DIAN-TU-001 Trial Results |
| July 27, 2021 | No Seminar | AAIC Conference | |
| July 20, 2021 | No Seminar | Pre-AAIC Poster Session | |
| July 13, 2021 | Erik Musiek, MD, PhD & B. Joy Snider, MD, PhD | WashU Medicine | Aducanamab – what we know so far |
| July 6, 2021 | Chengran Yang, PhD | WashU Medicine | Identifying the protein quantitative trait loci (pQTLs) from participants with and without an Alzheimer Disease (AD) diagnosis |
| June 29, 2021 | John C. Morris, MD | WashU Medicine | State of the Knight ADRC |
| June 22, 2021 | Matt Gable, PhD | WashU | Recruitment and retention in longitudinal Alzheimer disease studies: Insights from a survey of ADRC study participants |
| June 15, 2021 | Logan Brase | WashU Medicine | Single-nucleus RNA sequencing identifies altered cell-specific expression profiles driven by Alzheimer Disease genetic variants |
| June 8, 2021 | Robert Fucetola, PhD | WashU Medicine | Indications for Neuropsychological Testing in the Dementia Evaluation |
| June 1, 2021 | Joyce (Joy) Balls-Berry, PhD, MPE | WashU Medicine | Understanding the Construct of Race in the Context of Racial Differences and Disparities in ADRD Research |
| May 25, 2021 | Suzanne Schindler, MD | WashU Medicine | New data on blood-based and CSF biomarkers in the Knight ADRC cohort |
| May 18, 2021 | Gregory VanSternen, MD | WashU Medicine | Retinal Imaging and Alzheimer’s Disease |
| May 11, 2021 | No Seminar | Annual Hope Center Retreat | |
| May 4, 2021 | Lauren Koenig | WashU Medicine | Impact of Race and AD in an Acute Stroke Cohort |
| April 27, 2021 | Joy Snider, MD | WashU Medicine | Clinical Trials Update 2021 – Knight ADRC Clinical Trials Unit |
| April 20, 2021 | Karin Meeker, PhD | WashU Medicine | Cognitive Intraindividual Variability, Phosphorylated Tau Sites, and Functional Brain Organization in AD |
| April 13, 2021 | Patrick Luckett, PhD | WashU Medicine | Clustering Biomarkers in Dominantly Inherited Alzheimer’s Disease |
| April 6, 2021 | Charles Chen & Austin McCullough, PhD | WashU Medicine | Longitudinal PET amyloid- shows radiotracer-specific drug effects in the DIAN-TU-001 trial || Regional effects of gantenerumab on neuroimaging biomarkers in the Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU) |
| March 30, 2021 | David Balota, PhD | WashU Medicine | Personality, Alzheimers Disease, and Biomarkers |
| March 23, 2021 | No Seminar | ||
| March 16, 2021 | Albert Lai, PhD | WashU Medicine | Precision Medicine Initiative for Alzheimer Disease using BJC Electronics Health Records Data |
| March 9, 2021 | Brian Gordon, PhD | WashU Medicine | Ca(tau)strophe: comparing CSF and Imaging measures of tau. |
| March 2, 2021 | Susan Criswell, MD | WashU Medicine | Neuroimaging in Occupational and Environmental Manganese Neutoxicity |
| February 23, 2021 | Erik Musiek, MD, PhD | WashU Medicine | Circadian clocks, glia, and Alzheimer’s Disease |
| February 16, 2021 | Chengjie Xiong, PhD | WashU Medicine | Biostatistics Core and Database Updates: ADRC, HASD, ACS, and DIAN |